AstraZeneca should stick to its winning formula. It doesn’t need a $400bn US mega-merger
--------------------------------------------------------------------
Source: Guardian Australia
Published: 2026-08-04 03:22 UTC+10:00
Section: AstraZeneca
Factuality Score: 100
Opinion Category: Neutral
Topics: Business & Economy
--------------------------------------------------------------------
Snippet:
The Anglo-Swedish drugmaker’s flirtation with a grand combo with US group Bristol Myers Squibb is baffling
--------------------------------------------------------------------